ASAmalia Stantzou

Amalia Stantzou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Amalia Stantzou has a total of 70 co-authors. Here are the top co-authors by number of shared publications:

  • Helge Amthor

    Hôpital Raymond Poincaré Department of Pediatric Neurology and Intensive Care, Pediatric Physical Medicine and Rehabilitation Garches 92380

    5 shared publications
  • Markus Schuelke

    Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, Berlin, Germany

    4 shared publications
  • Luis Garcia

    Evolution of Neuromuscular Diseases - Innovative Concepts and Practice (END-ICAP) U1179, Université Paris-Saclay, Université de Versailles Saint-Quentin-en-Yvelines, Inserm, 78000 Versailles, France

    3 shared publications
  • Adrien Morin

    Evolution of Neuromuscular Diseases - Innovative Concepts and Practice (END-ICAP) U1179, Université Paris-Saclay, Université de Versailles Saint-Quentin-en-Yvelines, Inserm, 78000 Versailles, France

    2 shared publications
  • Arnaud Ferry

    Center for Research in Myology Pierre et Marie Curie University Paris Sorbonne INSERM UMRS974 CNRS FRE3617 Paris France

    2 shared publications
  • Arnaud Ferry

    Centre de Recherche en Myologie, UMRS974-Sorbonne Université-INSERM U974-Association Institut de Myologie, France

    2 shared publications

Latest Publications

  • BMP signaling controls postnatal muscle development

    by Amalia Stantzou

    La signalisation BMP contrôle le développement musculaire postnatal: Les "Bone Morphogenetic Proteins" (BMPs) jouent un rôle clef dans la régulation de cellules précurseurs du muscle prénatal et de cellules souches musculaires adultes dénommées "cellules satellites". Les objectifs principaux de ma thèse étaient d'une part de déterminer si la signalisation BMP joue un rôle pendant la phase de croissance du muscle postnatale/juvénile dépendante des cellules satellites, et d'autre part d'investiguer si cette voie est impliquée dans la maintenance de la masse musculaire squelettique adulte. J'ai trouvé que les composants de cette voie de signalisation sont exprimés dans les cellules satellites de souris néonatales, juvéniles et adultes. Par ailleurs, j'ai utilisé des lignées de souris transgéniques pour surexprimer, de manière conditionnelle, l'inhibiteur Smad6 de la cascade de signalisation BMP dans les cellules satellites ou dans le muscle squelettique. J'ai pu ainsi démontrer que cette signalisation est requise pour une prolifération correcte des cellules satellites et pour leur différentiation en myonuclei, assurant que les fibres musculaires en croissance atteignent une taille finale normale. Par ailleurs, mes travaux révèlent que le nombre final de cellules satellites est établis pendant la phase de croissance postnatale/juvénile et que celle-ci dépend de la cascade de signalisation BMP. Enfin, je fournis des preuves montrant que la signalisation BMP est un puissant signal hypertrophique dans le muscle squelettique adulte et que sa présence est indispensable pour le maintien du tissu musculaire. En résumé, mes résultats de recherche démontrent que les BMPs sont des facteurs de croissance essentiels pour le muscle squelettique postnatal.


  • Inhibitory SMAD6 interferes with BMP dependent generation of muscle progenitor cells and perturbs proximodistal pattern of murine limb muscles

    by Hasan Asfour, Estelle Hirsinger, Raquel Rouco, Faouzi Zarrouki, Shinichiro Hayashi, Sandra Swist, Thomas Braun, Ketan Patel, Frédéric Relaix, Guillaume Andrey, et al.

    The mechanism of pattern formation during limb muscle development remains poorly understood. The canonical view holds that naïve limb muscle progenitor cells (MPCs) invade a pre-established pattern of muscle connective tissue, thereby forming individual muscles. Here we show that early murine embryonic limb MPCs highly accumulate pSMAD1/5/9, demonstrating active signaling of bone morphogenetic proteins (BMP) in these cells. Overexpression of inhibitory SMAD6 in limb MPCs abrogated BMP signaling, impaired their migration and proliferation, and accelerated myogenic lineage progression. Fewer primary myofibers developed, causing an aberrant proximodistal muscle pattern. Patterning was not disturbed when SMAD6 was overexpressed in differentiated muscle, implying that the proximodistal muscle pattern depends on BMP-mediated expansion of MPCs prior to their differentiation. We show that limb MPCs differentially express Hox genes, and Hox-expressing MPCs displayed active BMP signaling. SMAD6 overexpression caused loss of HOXA11 in early limb MPCs. In conclusion, our data show that BMP signaling controls expansion of embryonic limb MPC as a prerequisite for establishing the proximodistal muscle pattern, a process that involves expression of Hox genes.


  • Open Access

    Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle

    by Adrien Morin, Amalia Stantzou, Olga N. Petrova, John Hildyard, Thomas Tensorer, Meriem Matouk, Mina V. Petkova, Isabelle Richard, Tudor Manoliu, Aurélie Goyenvalle, et al.

    Dystrophin is essential for muscle health: its sarcolemmal absence causes the fatal, X-linked condition, Duchenne muscular dystrophy (DMD). However, its normal, spatial organization remains poorly understood, which hinders the interpretation of efficacy of its therapeutic restoration. Using female reporter mice heterozygous for fluorescently tagged dystrophin ( Dmd EGFP ), we here reveal that dystrophin distribution is unexpectedly compartmentalized, being restricted to myonuclear-defined sarcolemmal territories extending ~80 µm, which we called “basal sarcolemmal dystrophin units (BSDUs).” These territories were further specialized at myotendinous junctions, where both Dmd transcripts and dystrophin protein were enriched. Genome-level correction in X-linked muscular dystrophy mice via CRISPR/Cas9 gene editing restored a mosaic of separated dystrophin domains, whereas transcript-level Dmd correction, following treatment with tricyclo-DNA antisense oligonucleotides, restored dystrophin initially at junctions before extending along the entire fiber—with levels ~2% sufficient to moderate the dystrophic process. We conclude that widespread restoration of fiber dystrophin is likely critical for therapeutic success in DMD, perhaps most importantly, at muscle–tendon junctions.


  • Open Access

    Extracellular matrix remodelling is associated with muscle force increase in overloaded mouse plantaris muscle

    by Amalia Stantzou, Karima Relizani, Susanne Morales‐Gonzalez, Charles Gallen, Antoine Grassin, Arnaud Ferry, Markus Schuelke, Helge Amthor

    Aims: Transforming growth factor‐β (TGF‐β) signalling is thought to contribute to the remodelling of extracellular matrix (ECM) of skeletal muscle and to functional decline in patients with muscular dystrophies. We wanted to determine the role of TGF‐β‐induced ECM remodelling in dystrophic muscle.Methods: We experimentally induced the pathological hallmarks of severe muscular dystrophy by mechanically overloading the plantaris muscle in mice. Furthermore, we determined the role of TGF‐β signalling on dystrophic tissue modulation and on muscle function by (i) overloading myostatin knockout (Mstn−/−) mice and (ii) by additional pharmacological TGF‐β inhibition via halofuginone.Results: Transcriptome analysis of overloaded muscles revealed upregulation predominantly of genes associated with ECM, inflammation and metalloproteinase activity. Histology revealed in wild‐type mice signs of severe muscular dystrophy including myofibres with large variation in size and internalized myonuclei, as well as increased ECM deposition. At the same time, muscle weight had increased by 208% and muscle force by 234%. Myostatin deficiency blunted the effect of overload on muscle mass (59% increase) and force (76% increase), while having no effect on ECM deposition. Concomitant treatment with halofuginone blunted overload‐induced muscle hypertrophy and muscle force increase, while reducing ECM deposition and increasing myofibre size.Conclusions: ECM remodelling is associated with an increase in muscle mass and force in overload‐modelled dystrophic muscle. Lack of myostatin is not advantageous and inhibition of ECM deposition by halofuginone is disadvantageous for muscle plasticity in response to stimuli that induce dystrophic muscle.


  • Open Access

    Live‐imaging of revertant and therapeutically restored dystrophin in the DmdEGFP‐mdx mouse model for Duchenne muscular dystrophy

    by Mina V. Petkova, Amalia Stantzou, Adrien Morin, Olga Petrova, Susanne Morales‐Gonzalez, Franziska Seifert, Jessica Bellec‐Dyevre, Tudor Manoliu, Aurélie Goyenvalle, Luis Garcia, et al.

    Background Dmdmdx, harbouring the c.2983C>T nonsense mutation in Dmd exon 23, is a mouse model for Duchenne muscular dystrophy (DMD), frequently used to test therapies aimed at dystrophin restoration. Current translational research is methodologically hampered by the lack of a reporter mouse model, which would allow direct visualization of dystrophin expression as well as longitudinal in vivo studies. Methods We generated a DmdEGFP‐mdx reporter allele carrying in cis the mdx‐ 23 mutation and a C‐terminal EGFP‐tag. This mouse model allows direct visualization of spontaneously and therapeutically restored dystrophin‐EGFP fusion protein either after natural fibre reversion, or for example, after splice modulation using tricyclo‐DNA to skip Dmd exon 23, or after gene editing using AAV‐encoded CrispRCas9 for Dmd exon 23 excision. Results Intravital microscopy in anaesthetised mice allowed live‐imaging of sarcolemmal dystrophin‐EGFP fusion protein of revertant fibres as well as following therapeutic restoration. Dystrophin‐EGFP‐fluorescence persisted ex vivo , allowed live‐imaging of revertant and therapeutically restored dystrophin in isolated fibres ex vivo . Expression of the shorter dystrophin‐EGFP isoforms Dp71 in brain, Dp260 in the retina, and Dp116 in the peripheral nerve remained unabated by the mdx‐ 23 mutation. Conclusion Intravital imaging of DmdEGFP‐mdx muscle permits novel experimental approaches such as the study of revertant and therapeutically restored dystrophin in vivo and ex vivo.


  • Open Access

    BMP signaling regulates satellite cell-dependent postnatal muscle growth

    by Amalia Stantzou, Elija Schirwis, Sandra Swist, Sonia Alonso-Martin, Ioanna Polydorou, Faouzi Zarrouki, Etienne Mouisel, Cyriaque Beley, Anaïs Julien, Fabien Le Grand, et al.

    Postnatal growth of skeletal muscle largely depends on the expansion and differentiation of resident stem cells, the so-called satellite cells. Here, we demonstrate that postnatal satellite cells express components of the bone morphogenetic protein (BMP) signaling machinery. Overexpression of noggin in postnatal mice (to antagonize BMP ligands), satellite cell-specific knockout of Alk3 (the gene encoding the BMP transmembrane receptor) or overexpression of inhibitory SMAD6 decreased satellite cell proliferation and accretion during myofiber growth, and ultimately retarded muscle growth. Moreover, reduced BMP signaling diminished the adult satellite cell pool. Abrogation of BMP signaling in satellite cell-derived primary myoblasts strongly diminished cell proliferation and upregulated the expression of cell cycle inhibitors p21 and p57. In conclusion, these results show that BMP signaling defines postnatal muscle development by regulating satellite cell-dependent myofiber growth and the generation of the adult muscle stem cell pool.


  • Gonad-related factors promote muscle performance gain during postnatal development in male and female mice

    by Vanessa Ueberschlag-Pitiot, Amalia Stantzou, Julien Messéant, Megane Lemaitre, Daniel J. Owens, Philippe Noirez, Pauline Roy, Onnik Agbulut, Daniel Metzger, Arnaud Ferry

    To better define the role of male and female gonad-related factors (MGRF, presumably testosterone, and FGRF, presumably estradiol, respectively) on mouse hindlimb skeletal muscle contractile performance/function gain during postnatal development, we analyzed the effect of castration initiated before puberty in male and female mice. We found that muscle absolute and specific (normalized to muscle weight) maximal forces were decreased in 6-mo-old male and female castrated mice compared with age- and sex-matched intact mice, without alteration in neuromuscular transmission. Moreover, castration decreased absolute and specific maximal powers, another important aspect of muscle performance, in 6-mo-old males, but not in females. Absolute maximal force was similarly reduced by castration in 3-mo-old muscle fiber androgen receptor (AR)-deficient and wild-type male mice, indicating that the effect of MGRF was muscle fiber AR independent. Castration reduced the muscle weight gain in 3-mo mice of both sexes and in 6-mo females but not in males. We also found that bone morphogenetic protein signaling through Smad1/5/9 was not altered by castration in atrophic muscle of 3-mo-old mice of both sexes. Moreover, castration decreased the sexual dimorphism regarding muscle performance. Together, these results demonstrated that in the long term, MGRF and FGRF promote muscle performance gain in mice during postnatal development, independently of muscle growth in males, largely via improving muscle contractile quality (force and power normalized), and that MGFR and FGRF also contribute to sexual dimorphism. However, the mechanisms underlying MGFR and FGRF actions remain to be determined.


  • Effect of constitutive inactivation of the myostatin gene on the gain in muscle strength during postnatal growth in two murine models

    by Amalia Stantzou, Vanessa Ueberschlag‐Pitiot, Remi Thomasson, Denis Furling, Anne Bonnieu, Helge Amthor, Arnaud Ferry

    Introduction: The effect of constitutive inactivation of the gene encoding myostatin on the gain in muscle performance during postnatal growth has not been well characterized. Methods: We analyzed 2 murine myostatin knockout (KO) models, (i) the Lee model (KOLee) and (ii) the Grobet model (KOGrobet), and measured the contraction of tibialis anterior muscle in situ. Results: Absolute maximal isometric force was increased in 6‐month‐old KOLee and KOGrobet mice, as compared to wild‐type mice. Similarly, absolute maximal power was increased in 6‐month‐old KOLee mice. In contrast, specific maximal force (relative maximal force per unit of muscle mass was decreased in all 6‐month‐old male and female KO mice, except in 6‐month‐old female KOGrobet mice, whereas specific maximal power was reduced only in male KOLee mice. Conclusions: Genetic inactivation of myostatin increases maximal force and power, but in return it reduces muscle quality, particularly in male mice. Muscle Nerve 55: 254–261, 2017


  • Top Cited Papers

    BMP signaling controls muscle mass

    by Roberta Sartori, Elija Schirwis, Bert Blaauw, Sergia Bortolanza, Jinghui Zhao, Elena Enzo, Amalia Stantzou, Etienne Mouisel, Luana Toniolo, Arnaud Ferry, et al.

    Cell size is determined by the balance between protein synthesis and degradation. This equilibrium is affected by hormones, nutrients, energy levels, mechanical stress and cytokines. Mutations that inactivate myostatin lead to excessive muscle growth in animals and humans, but the signals and pathways responsible for this hypertrophy remain largely unknown. Here we show that bone morphogenetic protein (BMP) signaling, acting through Smad1, Smad5 and Smad8 (Smad1/5/8), is the fundamental hypertrophic signal in mice. Inhibition of BMP signaling causes muscle atrophy, abolishes the hypertrophic phenotype of myostatin-deficient mice and strongly exacerbates the effects of denervation and fasting. BMP-Smad1/5/8 signaling negatively regulates a gene (Fbxo30) that encodes a ubiquitin ligase required for muscle loss, which we named muscle ubiquitin ligase of the SCF complex in atrophy-1 (MUSA1). Collectively, these data identify a critical role for the BMP pathway in adult muscle maintenance, growth and atrophy.